Royal Bank of Canada’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-76,298
| Closed | -$2.23M | – | 7284 |
|
|
2017
Q3 | $2.23M | Sell |
76,298
-46,604
| -38% | -$1.31M | ﹤0.01% | 2575 |
|
|
2017
Q2 | $3.23M | Sell |
122,902
-8,362
| -6% | -$206K | ﹤0.01% | 2246 |
|
|
2017
Q1 | $3.07M | Buy |
131,264
+22,744
| +21% | +$561K | ﹤0.01% | 2236 |
|
|
2016
Q4 | $2.73M | Sell |
108,520
-17,684
| -14% | -$446K | ﹤0.01% | 2347 |
|
|
2016
Q3 | $3.54M | Buy |
126,204
+2,755
| +2% | +$70.6K | ﹤0.01% | 2137 |
|
|
2016
Q2 | $3.04M | Buy |
123,449
+2,535
| +2% | +$62.9K | ﹤0.01% | 2213 |
|
|
2016
Q1 | $2.67M | Sell |
120,914
-7,657
| -6% | -$204K | ﹤0.01% | 2243 |
|
|
2015
Q4 | $4.5M | Buy |
128,571
+4,518
| +4% | +$142K | ﹤0.01% | 1935 |
|
|
2015
Q3 | $3.53M | Buy |
124,053
+42,516
| +52% | +$1.43M | ﹤0.01% | 1802 |
|
|
2015
Q2 | $2.71M | Buy |
81,537
+4,866
| +6% | +$149K | ﹤0.01% | 2081 |
|
|
2015
Q1 | $2.16M | Sell |
76,671
-10,361
| -12% | -$258K | ﹤0.01% | 2213 |
|
|
2014
Q4 | $1.8M | Buy |
87,032
+16,310
| +23% | +$387K | ﹤0.01% | 2419 |
|
|
2014
Q3 | $1.73M | Buy |
70,722
+17,544
| +33% | +$465K | ﹤0.01% | 2422 |
|
|
2014
Q2 | $1.52M | Sell |
53,178
-2,867
| -5% | -$79.7K | ﹤0.01% | 2499 |
|
|
2014
Q1 | $1.57M | Buy |
56,045
+6,105
| +12% | +$150K | ﹤0.01% | 2422 |
|
|
2013
Q4 | $1.07M | Sell |
49,940
-14,291
| -22% | -$260K | ﹤0.01% | 2767 |
|
|
2013
Q3 | $853K | Sell |
64,231
-8,483
| -12% | -$114K | ﹤0.01% | 2908 |
|
|
2013
Q2 | $1.01M | Buy |
+72,714
| New | +$1.03M | ﹤0.01% | 2570 |
|
Royal Bank of Canada's PMC Position: Q4 2017 in Review
Royal Bank of Canada sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 76,298 shares — an estimated $2.23M sold.
Royal Bank of Canada first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $4.5M in Q4 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Royal Bank of Canada reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Royal Bank of Canada sold 76,298 PharMerica Corporation shares in Q4 2017, an estimated $2.23M.
- Royal Bank of Canada first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Royal Bank of Canada's PharMerica Corporation position peaked at $4.5M in Q4 2015.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.